In Nutritional deficiencies Zunalgia Plus Injection is a nutritional supplement that helps in proper functioning of the brain, heart and the nervous system. It also helps in formation of red blood cells and enhances the absorption of iron in the body. This improves the level of hemoglobin and thus reduces the risk of anemia. It helps boost energy and reduce fatigue. Apart from this, Zunalgia Plus Injection helps in maintaining healthy hair and skin.
Caution is advised when consuming alcohol with Zunalgia Plus Injection. Please consult your doctor.
Information regarding the use of Zunalgia Plus Injection during pregnancy is not available. Please consult your doctor.
Zunalgia Plus Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Zunalgia Plus Injection does not usually affect your ability to drive.
Zunalgia Plus Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Zunalgia Plus Injection may not be needed in these patients. Please consult your doctor.
Zunalgia Plus Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Zunalgia Plus Injection may not be needed in these patients. Please consult your doctor.
If you miss a dose of Zunalgia Plus Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More